Literature DB >> 15482629

Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial.

David S Janowsky1, Mahesh Shetty, Jarrett Barnhill, Belal Elamir, John M Davis.   

Abstract

There is a growing body of evidence that serotonergic antidepressants are useful in the treatment of maladaptive behaviours in the intellectually disabled. However, not all studies have shown positive results due to lack of efficacy, tolerance development, and troublesome side-effects. The current study consisted of a review of the treatment response to a variety of serotonergic antidepressants, consisting of selective serotonin reuptake inhibitors (SSRIs ) (n = 36) and clomipramine (n = 2) in 38 institutionalized intellectually disabled adults (20 males, 18 females; mean age 45.6 yr, age range 18-74 yr). Those studied were treated for aggression, self-injurious behaviours, destructive/disruptive behaviours, depression/dysphoria, or a combination of these or other challenging behaviours. Most were receiving concurrent psychotropic and/or anticonvulsant medications. Effectiveness was determined by a retrospective review of the summaries of multidisciplinary Neuropsychiatric Behavioural Reviews (NBRs) in which global and specific maladaptive behaviours were rated on a 1- to 7-point scale, and by psychologists' ratings of target behaviours. Overall, statistically significant decreases in the ratings of global maladaptive behaviour and aggression, self-injurious behaviour, destruction/disruption and depression/dysphoria and in psychologists' ratings occurred in the subject group after the initiation of antidepressants. The results suggest that serotonergic antidepressants are useful in the treatment of challenging/maladaptive behaviours in the intellectually disabled.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482629     DOI: 10.1017/S146114570400481X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  8 in total

1.  Behaviour disorders in children with an intellectual disability.

Authors:  Stacey Ageranioti-Bélanger; Suzanne Brunet; Guy D'Anjou; Geneviève Tellier; Johanne Boivin; Marie Gauthier
Journal:  Paediatr Child Health       Date:  2012-02       Impact factor: 2.253

2.  Serotonin depletion counteracts sex differences in anxiety-related behaviour in rat.

Authors:  Jakob Näslund; Erik Studer; Karin Nilsson; Lars Westberg; Elias Eriksson
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

Review 3.  Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment.

Authors:  Patricia Oliver-Africano; Declan Murphy; Peter Tyrer
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

Review 4.  A review of empirical evidence of somatic treatment options for the MI/DD population.

Authors:  Thaddeus P Ulzen; Richard E Powers
Journal:  Psychiatr Q       Date:  2008-08-23

Review 5.  Diagnosis and treatment of mood disorders in adults with developmental disabilities.

Authors:  Diana J Antonacci; Nadir Attiah
Journal:  Psychiatr Q       Date:  2008-08-23

Review 6.  Diagnosis and treatment of aggression in individuals with developmental disabilities.

Authors:  Diana J Antonacci; Crystal Manuel; Ervin Davis
Journal:  Psychiatr Q       Date:  2008-08-23

Review 7.  Diagnosis and treatment of depression in patients with mental retardation.

Authors:  David S Janowsky; John M Davis
Journal:  Curr Psychiatry Rep       Date:  2005-12       Impact factor: 8.081

8.  Recognition and treatment of mood dysregulation in adults with intellectual disability.

Authors:  Jason Noel
Journal:  Ment Health Clin       Date:  2018-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.